Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Wockhardt Ltd

+ Add to Watchlist

WPL:IN

1,660.40 INR 76.70 4.84%

As of 06:06:37 ET on 03/02/2015.

Snapshot for Wockhardt Ltd (WPL)

Open: 1,597.65 Day's Range: 1,498.45 - 1,666.00 Volume: 2,309,032
Previous Close: 1,583.70 52wk Range: 432.00 - 1,666.00 1-Yr Rtn: +284.83%

Stock Chart for WPL

No chart data available.
  • WPL:IN 1,660.40
  • 1D
  • 1M
  • 1Y
1,583.70
Interactive WPL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for WPL

Current P/E Ratio (ttm) 21.6649
Estimated P/E(03/2015) 47.4197
Relative P/E vs. SENSEX 1.0636
Earnings Per Share (INR) (ttm) 76.6400
Est. EPS (INR) (03/2015) 35.0150
Est. PEG Ratio -
Market Cap (M INR) 182,740.56
Shares Outstanding (M) 110.06
30 Day Average Volume 2,125,860
Price/Book (mrq) 5.2579
Price/Sale (ttm) 3.7706
Dividend Indicated Gross Yield 1.20%
Cash Dividend (INR) 20.0000
Dividend Ex-Date 11/13/2014
5 Year Dividend Growth -
Next Earnings Announcement 05/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for WPL

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for WPL

Wockhardt Limited, spun off from Wockhardt Life Sciences Limited, specializes in the production of pharmaceuticals, in both generic and prescription forms. The Company has develop brands in a variety of segments, including anti-infectives, pain & inflammation, cough, psychiatry, medical nutrition, vaccines, active pharmaceutical ingredients and bio-technology.

Habil F KhorakiwalaChairman/CEO/FounderMurtaza H KhorakiwalaManaging Director
Manas DattaChief Financial OfficerHuzaifa KhorakiwalaExecutive Director
More Company Profile & Key Executives for WPL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil